Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 5/20 | 0.63 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.45 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.42 |
| ▸ | FNTB | P49356 | 2/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
| ▸ | BMP1 | P13497 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29368560 | 1.00 | FOLH1 (0.63) | FOLH1ENPEPRIMKLANAALAD2FNTA | |
| SCHEMBL30234159 | 1.00 | FOLH1 (0.63) | FOLH1ENPEPRIMKLANAALAD2FNTA | |
| SCHEMBL30811199 | 1.00 | FOLH1 (0.63) | FOLH1ENPEPRIMKLANAALAD2FNTA | |
| SCHEMBL23857928 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL29642982 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL30307570 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL30307583 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL31520392 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL30856932 | 0.93 | FOLH1 (0.51) | FOLH1FNTAFNTBPGGT1BGSR | |
| SCHEMBL31679371 | 0.92 | FOLH1 (0.50) | FOLH1FNTAFNTBPGGT1BGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4171621-A1 | C825 EXPRESSING IMMUNE CELLS AND DIAGNOSTIC USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2023-05-03 | — | — | EP | claimed |
| EP-4419567-A2 | ANTI-TSHR MULTI-SPECIFIC ANTIBODIES AND USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-4171621-A1 | C825 EXPRESSING IMMUNE CELLS AND DIAGNOSTIC USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2023-05-03 | — | — | EP | disclosed |
| WO-2023069341-A2 | ANTI-TSHR MULTI-SPECIFIC ANTIBODIES AND USES THEREOF | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-4025609-A1 | ANTI-STEAP1 ANTIBODIES AND USES THEREOF | Memorial Sloan Kettering Cancer Center (US) | 2022-07-13 | — | — | EP | disclosed |
| EP-3990022-A1 | ANTI-CD33 ANTIBODIES FOR TREATING CANCER | Memorial Sloan Kettering Cancer Center (US) | 2022-05-04 | — | — | EP | disclosed |